These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 7489753

  • 1. Natural antibodies against the immunoglobulin F(ab')2 fragment cause elimination of antigens recognized by the F(ab')2 from the circulation.
    Yano S, Kaku S, Suzuki K, Terazaki C, Sakayori T, Kawasaki T, Kawamura K, Sugita Y, Hoshino K, Masuho Y.
    Eur J Immunol; 1995 Nov; 25(11):3128-33. PubMed ID: 7489753
    [Abstract] [Full Text] [Related]

  • 2. [Inhibition of thrombocyte aggregation by F(ab')2-fragments of monoclonal antibodies FraMon (CRC64) to glycoproteins IIb-IIIa].
    Mazurov AV, Pevzner DV, Khaspekova SG, Dudnik OA, Byzova TV, Vlasik TN, Bakharev VN, Pistsov MIu, Staroverov II, Ruda MIa.
    Ter Arkh; 2001 Nov; 73(9):66-73. PubMed ID: 11642086
    [Abstract] [Full Text] [Related]

  • 3. [Identification of human platelet specific functional antibody and its fragments].
    Chu XX, Hou M, Zhu YY, Peng J, Ji XB, Zhang F, Wang L.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 28; 85(49):3464-8. PubMed ID: 16686061
    [Abstract] [Full Text] [Related]

  • 4. Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty.
    Mazurov AV, Pevzner DV, Antonova OA, Byzova TV, Khaspekova SG, Semenov AV, Vlasik TN, Samko AN, Staroverov II, Ruda MY.
    Platelets; 2002 Dec 28; 13(8):465-77. PubMed ID: 12487780
    [Abstract] [Full Text] [Related]

  • 5. A novel mechanism for exposure of fibrinogen binding sites on GPIIb-IIIa by a monoclonal antibody.
    Hato T, Watanabe A, Nakatani S, Minamoto Y, Fujita S.
    Thromb Haemost; 1995 Jan 28; 73(1):138-43. PubMed ID: 7537917
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the antiplatelet agent potential of the whole molecule, F(ab)2 and Fab fragments of humanized anti-GPIIb/IIIa monoclonal antibody in monkeys.
    Kaku S, Yano S, Kawasaki T, Sakai Y, Suzuki K, Kawamura K, Masuho Y, Satoh N, Takenaka T, Landolfi NF, Co MS.
    Gen Pharmacol; 1996 Apr 28; 27(3):435-9. PubMed ID: 8723521
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 7E3 F(ab')2, an effective antagonist of rat alphaIIbbeta3 and alphavbeta3, blocks in vivo thrombus formation and in vitro angiogenesis.
    Sassoli PM, Emmell EL, Tam SH, Trikha M, Zhou Z, Jordan RE, Nakada MT.
    Thromb Haemost; 2001 May 28; 85(5):896-902. PubMed ID: 11372685
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antiplatelet and antithrombotic effects of YM337, the Fab fragment of a humanized anti-GPIIb/IIIa monoclonal antibody in monkeys.
    Kaku S, Kawasaki T, Hisamichi N, Sakai Y, Taniuchi Y, Inagaki O, Yano S, Suzuki K, Terazaki C, Masuho Y, Satoh N, Takenaka T, Yanagi K, Ohshima N.
    Thromb Haemost; 1996 Apr 28; 75(4):679-84. PubMed ID: 8743199
    [Abstract] [Full Text] [Related]

  • 12. [The immunoreactivity of IgG and its fragments from ITP patients and their effects on platelet aggregation function].
    Chu XX, Hou M, Zhu YY, Peng J, Ji XB, Wang L, Zhang F, Ma DX.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Mar 28; 27(3):158-61. PubMed ID: 16792915
    [Abstract] [Full Text] [Related]

  • 13. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
    Holton OD, Black CD, Parker RJ, Covell DG, Barbet J, Sieber SM, Talley MJ, Weinstein JN.
    J Immunol; 1987 Nov 01; 139(9):3041-9. PubMed ID: 3499463
    [Abstract] [Full Text] [Related]

  • 14. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
    Brezski RJ, Kinder M, Grugan KD, Soring KL, Carton J, Greenplate AR, Petley T, Capaldi D, Brosnan K, Emmell E, Watson S, Jordan RE.
    MAbs; 2014 Nov 01; 6(5):1265-73. PubMed ID: 25517311
    [Abstract] [Full Text] [Related]

  • 15. Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists.
    Sirotkina OV, Khaspekova SG, Zabotina AM, Shimanova YV, Mazurov AV.
    Platelets; 2007 Nov 01; 18(7):506-14. PubMed ID: 17957566
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Exposure of platelet fibrinogen receptors by a monoclonal antibody to the GPIIb-IIIa complex, PMA4.
    Watanabe A, Hato T, Kobayashi Y.
    Int J Hematol; 1992 Aug 01; 56(1):79-87. PubMed ID: 1382664
    [Abstract] [Full Text] [Related]

  • 18. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model.
    Iwahashi T, Okochi E, Ariyoshi K, Watabe H, Amann E, Mori S, Tsuruo T, Ono K.
    Cancer Res; 1993 Nov 15; 53(22):5475-82. PubMed ID: 8106147
    [Abstract] [Full Text] [Related]

  • 19. Comparative localization of murine monoclonal antibody Me1-14 F(ab')2 fragment and whole IgG2a in human glioma xenografts.
    Colapinto EV, Humphrey PA, Zalutsky MR, Groothuis DR, Friedman HS, de Tribolet N, Carrel S, Bigner DD.
    Cancer Res; 1988 Oct 15; 48(20):5701-7. PubMed ID: 3167830
    [Abstract] [Full Text] [Related]

  • 20. Prevention of rethrombosis after coronary thrombolysis in a chronic canine model. I. Adjunctive therapy with monoclonal antibody 7E3 F(ab')2 fragment.
    Rote WE, Mu DX, Bates ER, Nedelman MA, Lucchesi BR.
    J Cardiovasc Pharmacol; 1994 Feb 15; 23(2):194-202. PubMed ID: 7511747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.